Edition:
United States

GlycoMimetics Inc (GLYC.OQ)

GLYC.OQ on NASDAQ Stock Exchange Global Market

12.47USD
3:59pm EST
Change (% chg)

$0.20 (+1.63%)
Prev Close
$12.27
Open
$12.30
Day's High
$12.73
Day's Low
$12.08
Volume
93,177
Avg. Vol
113,882
52-wk High
$16.94
52-wk Low
$3.83

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

M. James Barrett

74 2017 Independent Chairman of the Board

Rachel King

57 2003 President, Chief Executive Officer, Co-Founder, Director

John Magnani

64 2017 Co-Founder, Senior Vice President, Chief Scientific Officer, Director

Brian Hahn

42 2012 Chief Financial Officer

Helen Thackray

47 2017 Senior Vice President - Clinical Development, Chief Medical Officer